ABVC ABVC Biopharma
ABVC Biopharma earnings company data as of 8:00 PM ET 10/28
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 30 Oct | EPS | — | — | — |
| Rev | — | — | — |
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| DEF 14A | DEFINITIVE PROXY STATEMENT | Filing Doc | |
| 8-K | 1.01,2.01,7.01,9.01 | Filing Doc | |
| 424B4 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 424B4 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 424B4 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 424B4 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 8-K/A | 8.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 4.01,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 5.07,9.01 | Filing Doc | |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Filing Doc | |
| 8-K | 2.02,4.02,9.01 | Filing Doc | |
| 10-Q/A | AMENDMENT NO. 1 TO FORM 10-Q | Filing Doc | |
| 10-K | ANNUAL REPORT | Filing Doc | |
| 8-K/A | 3.02,9.01 | Filing Doc | |
| 424B4 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 424B4 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 424B4 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 424B4 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K/A | 4.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.